Medical University Innsbruck
i-med.ac.atLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
183
Active
50
Phase 3
7
Total enrollment
360,688
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Obinutuzumab | — | — | — | — | — | 1 | |
| Predniso(lo)ne | — | — | — | — | — | 1 | |
| neoadjuvant therapy with Pembrolizumab/Lenvatinib | — | — | — | — | — | 1 | |
| Adjuvant Treatment Phase | — | — | — | — | — | 1 | |
| Alfa1 Antitrypsin | — | — | — | — | — | 1 | |
| Blood sampling | — | — | — | — | — | 2 | |
| packed red blood cells | — | — | — | — | — | 1 |
Next readouts
- 2021-03-01
- 2023-12
- 2025-07
- 2028-06-30
- 2028-09
Top conditions
- COVID-196
- Atherosclerosis4
- Cardiovascular Diseases4
- Covid193
- Major Depressive Disorder3
- Heart Failure3
- Healthy3
- Apnea2
Frequently asked questions about Medical University Innsbruck
- How many clinical trials does Medical University Innsbruck have on ClinicalTrials.gov?
- Medical University Innsbruck is listed as the lead sponsor on 183 clinical trials in ClinicalTrials.gov, 50 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University Innsbruck's trials are in Phase 3?
- 7 of Medical University Innsbruck's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Medical University Innsbruck focus on?
- Medical University Innsbruck's most-studied conditions on ClinicalTrials.gov are COVID-19, Atherosclerosis, Cardiovascular Diseases, Covid19, Major Depressive Disorder.
- When are Medical University Innsbruck's next clinical trial readouts?
- Medical University Innsbruck has 5 upcoming primary-completion readouts tracked here; the soonest is “Connective Tissue Diseases and Lung Manifestations”, expected around 2021-03-01.